Wegovy

semaglutide · GLP-1 receptor agonist

What it is

Wegovy is a brand name for semaglutide dosed specifically for weight management. Like Ozempic, it is a once-weekly injectable GLP-1 receptor agonist, but it titrates to a higher maintenance dose.

What it's used for

FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition, and for some adolescents. It is used alongside reduced-calorie eating and increased physical activity.

Typical dosing schedule

Dosing schedules differ by person and are set by a prescriber. The pattern below is a commonly described escalation — it is informational only, not a recommendation.

DoseTypical timingNotes
0.25 mgWeeks 1–4Starting dose.
0.5 mgWeeks 5–8First step up.
1.0 mgWeeks 9–12Continued titration.
1.7 mgWeeks 13–16Continued titration.
2.4 mgWeek 17+Full maintenance dose.

Common side effects

Commonly reported side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, and fatigue, commonly during titration. Many people find symptoms ease over time, but persistent or severe symptoms should always be discussed with your prescriber. See our side-effects guide for management tips members commonly share.

Rough cost

Roughly $1,300–$1,400/month at US list price without insurance; manufacturer savings programs may apply for eligible patients.

Pricing varies widely. See our cost & insurance guide for savings programs, prior-authorization basics, and more.

Discuss it with the community

Read real member experiences and ask questions: